CD5 and neoplasm: CD5/CD7 bispecific CAR-T cells selectively killed tumor cells in a dose-dependent manner, but not CD5-CD7- Raji (Fig. 4a), demonstrating that CD5/CD7 bispecific CAR-T cells maintain good specificity.